0001209191-14-046017.txt : 20140703
0001209191-14-046017.hdr.sgml : 20140703
20140703164233
ACCESSION NUMBER: 0001209191-14-046017
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140701
FILED AS OF DATE: 20140703
DATE AS OF CHANGE: 20140703
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Horton Kenneth L
CENTRAL INDEX KEY: 0001552047
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 14961224
MAIL ADDRESS:
STREET 1: VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-07-01
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001552047
Horton Kenneth L
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP & Chief Legal Officer
Common Stock
2014-07-01
4
M
0
28321
45.11
A
62597
D
Common Stock
2014-07-01
4
S
0
2257
94.49
D
60340
D
Common Stock
2014-07-01
4
S
0
27877
95.28
D
32463
D
Common Stock
366
I
401(k)
Stock Option (right to buy)
45.11
2014-07-01
4
M
0
28321
0.00
D
2013-05-05
2023-02-04
Common Stock
28321
62304
D
Transaction made pursuant to Mr. Horton's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $94.49 (range $93.79 to $94.78).
Mr. Horton undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $95.28 (range $94.79 to $95.66).
Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 02/05/2013.
Kenneth L. Horton
2014-07-03